These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19915343)

  • 21. [Classification of lymphomas].
    Molina T; Diebold J; Audouin J
    Rev Prat; 2002 May; 52(9):951-8. PubMed ID: 12063760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
    Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
    Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathology and cytodiagnosis of malignant lymphoma--with special reference to WHO, Rappaport, and LSG classification systems].
    Namiki T
    Rinsho Byori; 1982 Jul; 30(7):779-91. PubMed ID: 6757489
    [No Abstract]   [Full Text] [Related]  

  • 24. [Revised WHO classification of tumors of hematopoietic and lymphoid tissues, 2017 (4th edition):lymphoid tumors].
    Polyatskin IL; Artemyeva AS; Krivolapov YA
    Arkh Patol; 2019; 81(3):59-65. PubMed ID: 31317932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The WHO (1997) classification of 370 cases of malignant lymphomas].
    He S; Zhang JB; Zhang JG; Yang SY; Han F
    Zhonghua Xue Ye Xue Za Zhi; 2003 Oct; 24(10):519-22. PubMed ID: 14690580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues.
    Cazzola M
    Blood; 2016 May; 127(20):2361-4. PubMed ID: 27069255
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinicopathological analysis of malignant lymphoma in Taiwan, defined according to the World Health Organization classification.
    Lee MY; Tan TD; Feng AC; Liu MC
    Haematologica; 2005 Dec; 90(12):1703-5. PubMed ID: 16330450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mature T- and NK cell neoplasms].
    Yamaguchi M
    Rinsho Ketsueki; 2009 Apr; 50(4):253-60. PubMed ID: 19404017
    [No Abstract]   [Full Text] [Related]  

  • 29. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview.
    Sabattini E; Bacci F; Sagramoso C; Pileri SA
    Pathologica; 2010 Jun; 102(3):83-7. PubMed ID: 21171509
    [No Abstract]   [Full Text] [Related]  

  • 30. Introduction to the Fifth Edition of the World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues.
    Naresh KN; Medeiros LJ;
    Mod Pathol; 2023 Dec; 36(12):100330. PubMed ID: 37716508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [World Health Organization (WHO) classification of malignant lymphoma--how is the WHO now?].
    Nakamura S
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):149-57. PubMed ID: 14997743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [WHO classification of tumors of hematopoietic and lymphoid tissues, 2022 (5th edition): lymphoid tumors].
    Baram DV; Asaulenko ZP; Spiridonov IN; Krivolapov YA
    Arkh Patol; 2023; 85(4):24-31. PubMed ID: 37530187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 2004 World Health Organization classification of pituitary tumors: what is new?
    Al-Shraim M; Asa SL
    Acta Neuropathol; 2006 Jan; 111(1):1-7. PubMed ID: 16328527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [From FAB and REAL to WHO as comprehensive classification for hematopoietic and lymphoid tissues].
    Tomonaga M
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():233-40. PubMed ID: 17474416
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pathological diagnosis and classification of lymphoma: present status in China].
    Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):289-90. PubMed ID: 20654149
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current concepts in classification of lymphoid tissue tumors].
    Novik AA
    Vestn Khir Im I I Grek; 2001; 160(4):101-7. PubMed ID: 11837154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathologist's view point. Part I--indolent lymphomas.
    Pileri SA; Ascani S; Sabattini E; Fraternali-Orcioni G; Poggi S; Piccioli M; Piccaluga PP; Gamberi B; Zinzani PL; Leoncini L; Falini B
    Haematologica; 2000 Dec; 85(12):1291-307. PubMed ID: 11114137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pathologist's view point. Part II --aggressive lymphomas.
    Pileri SA; Ascani S; Sabattini E; Fraternali-Orcioni G; Poggi S; Piccioli M; Piccaluga PP; Gamberi B; Zinzani PL; Leoncini L; Falini B
    Haematologica; 2000 Dec; 85(12):1308-21. PubMed ID: 11114138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Classification of malignant lymphoma. WHO international proposal].
    Diebold J
    Ann Pathol; 1998 Oct; 18(4):361-7. PubMed ID: 9827226
    [No Abstract]   [Full Text] [Related]  

  • 40. [1992 tumor classification/developments].
    Hermanek P
    Langenbecks Arch Chir Suppl Kongressbd; 1992; ():40-5. PubMed ID: 1493294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.